摘要
目的:膀胱癌发生发展的分子机制尚不清楚。膀胱癌是流行病学研究和了解临床意义的重要焦点。 目标:预防的主要目的是通过限制非遗传风险因素的暴露来实现,如吸烟、饮食、饮用水中的砷或工作场所或其他地方的芳香胺。目前膀胱癌的治疗受到肿瘤形态和相关获得性基因突变的影响。 方法:使用PubMed、Scopus、ResearchGate、谷歌、MEDLINE和ScienceDirect数据库进行文献检索,查找1984年至2020年初发表的膀胱癌研究。重点是关于流行病学风险因素和潜在的病理生理机制的文章。选择的文章使我们能够回顾这些因素以及分子和结构模式。 结果:膀胱癌有多种观点。这些文献提供了一些关于膀胱癌发展和进展的新见解,以及可能在临床和诊断实践中有用的生物标志物。结论:膀胱癌的分子途径有多种,且不断更新。此外,膀胱肿瘤的基因亚型还不清楚,需要进一步的详细分析。
关键词: 膀胱癌,膀胱癌发病机制,危险因素,NMIBC, MIBC,膀胱癌分子途径,膀胱癌组织学分类,免疫组化,PD-L1。
Current Medicinal Chemistry
Title:Bladder Cancer: Update on Risk Factors, Molecular and Ultrastructural Patterns
Volume: 28 Issue: 41
关键词: 膀胱癌,膀胱癌发病机制,危险因素,NMIBC, MIBC,膀胱癌分子途径,膀胱癌组织学分类,免疫组化,PD-L1。
摘要:
Objective: The molecular mechanisms of bladder cancer development and progression are not clear. Bladder cancer is an important focus for epidemiological studies and understanding clinical implications.
Goal: The primary aim of prevention is achieved by limiting exposure to non-genetic risk factors, such as smoking, diet, arsenic in drinking water, or aromatic amines at work or elsewhere. Current therapies for bladder cancer are affected by tumor morphology and associated acquired genetic mutations.
Methods: A literature search was performed using PubMed, Scopus, ResearchGate, Google, MEDLINE, and ScienceDirect databases to find studies of bladder cancer published between 1984 and early 2020. The focus was articles that address epidemiological risk factors and underlying pathophysiological mechanisms. Articles were selected that enabled our review of these factors as well as molecular and structural patterns.
Results: There are multiple views of bladder cancer. The literature offers several novel insights regarding the development and progression of bladder cancer and possible biomarkers that may be useful in clinical and diagnostic practice.
Conclusion: There are several molecular pathways associated with bladder cancer that are frequently updated. In addition, genetic subtypes of bladder tumors are not distinguished clearly which requires future more detailed analysis.
Export Options
About this article
Cite this article as:
Bladder Cancer: Update on Risk Factors, Molecular and Ultrastructural Patterns, Current Medicinal Chemistry 2021; 28 (41) . https://dx.doi.org/10.2174/0929867328666210309111731
DOI https://dx.doi.org/10.2174/0929867328666210309111731 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Trends in Targeted Anticancer Prodrug and Conjugate Design
Current Medicinal Chemistry Impact of DMPEI on Biofilm Adhesion on Latex Urinary Catheter
Recent Patents on Biotechnology Thymidine Phosphorylase and Fluoropyrimidines Efficacy: A Jekyl and Hyde Story
Current Medicinal Chemistry - Anti-Cancer Agents Construction and Validation of a Nomogram for Predicting Progression- Free Survival in Patients with Early-Stage Testicular Germ Cell Tumor
Recent Patents on Anti-Cancer Drug Discovery A Computational Prediction of Conserved MicroRNA Targets of Ion Channels in Vertebrates
Current Bioinformatics microRNA, Cancer and Cancer Chemoprevention
Current Molecular Pharmacology Role for Poly(ADP-ribose) Polymerase Activation in Diabetic Nephropathy, Neuropathy and Retinopathy
Current Vascular Pharmacology Herbal Phytochemicals as Immunomodulators
Current Immunology Reviews (Discontinued) PTML Multi-Label Algorithms: Models, Software, and Applications
Current Topics in Medicinal Chemistry Tetrapyrrolic Macrocycles: Potentialities in Medical Imaging Technologies
Current Organic Synthesis Emerging Immunotargets in Bladder Cancer
Current Drug Targets Applications of the Rare Earth Elements in Cancer Imaging and Therapy
Current Nanoscience Targeted Enzyme Prodrug Therapies
Mini-Reviews in Medicinal Chemistry The Therapeutic Potential of ADAM15
Current Pharmaceutical Design New Pharmacologic Horizons in the Treatment of Benign Prostatic Hyperplasia
Current Drug Therapy Spectral Perspective on the Electromagnetic Activity of Cells
Current Topics in Medicinal Chemistry Mitochondrial Drug Targets in Cell Death and Cancer
Current Pharmaceutical Design Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?
Current Drug Targets Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications
Current Drug Targets DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening
Current Molecular Medicine